ÂÜÀòÂÒÂ×

Matthew Rosenberg, MD, currently serves as an Analyst at Rock Springs Capital and has been an Investor at Tekening Capital since 2018, focusing on early-stage technology startups. Additionally, Matthew provides advisory services to several companies, including MBX Capital, Thalys Medical Technology Inc, Rivia Health, Backflip, PrefTech, Edvo, Visby.io, and BlocHealth, contributing expertise in venture capital, healthcare, and innovative technologies. Matthew holds an AB in Economics from Harvard University and a Doctor of Medicine (MD) from Yale School of Medicine.